[SP01-1]Thrombo-inflammation in ischemic stroke: concept and mechanisms
○Bernhard Nieswandt(Institute of Experimental Biomedicine, University Hospital and Rudolf Virchow Center, University of Würzburg, Würzburg, Germany)
第42回日本血栓止血学会学術集会
Jul 1 - Jul 31, 2020オンライン開催
You can search for presentations in this event.
Search第42回日本血栓止血学会学術集会
Jul 1 - Jul 31, 2020オンライン開催
You can search for presentations in this event.
SearchSearch Results(276)
[SP02-1]脂肪由来生体防御因子アディポネクチンの作用発現機構と治療学展望
○下村 伊一郎(大阪大学大学院医学系研究科内分泌・代謝内科学)
[SP03-1]Glycans in platelet life-span and thrombopoiesis
○Karin M Hoffmeister(Translational Glycomics Center, Blood Research Institute, Versiti, Milwaukee, WI, USA)
[SP04-1]アテローム血栓症における血栓形成機序
○浅田 祐士郎(宮崎大学医学部病理学講座構造機能病態学分野)
[EL01-1]後天性血栓性血小板減少性紫斑病の治療
○上田 恭典(公益財団法人大原記念倉敷中央医療機構倉敷中央病院血液内科)
[EL02-1]新規血友病治療製剤がもたらす血友病医療のパラダイムシフトと血液凝固機序の新展開
○野上 恵嗣(奈良県立医科大学小児科)
[EL03-1]血液腫瘍内科医から見た血小板・血栓とアスピリン
○横山 健次(東海大学医学部付属八王子病院血液腫瘍内科)
[EL04-1]止血機能検査：特に凝固スクリーニング検査の重要性・正確性を考察する
○家子 正裕(岩手県立中部病院血液内科・臨床検査科)
[EL05-1]外科医よりみた血栓性疾患
○池田 正孝(兵庫医科大学外科学講座下部消化管外科)
[PL01-1]アンチトロンビンレジスタンス：FII分子異常による血栓制御バランス不全
○小嶋 哲人1,2(1.愛知健康増進財団, 2.名古屋大学)
[PL01-2]血小板機能異常症解析からのメッセージ：血小板血栓制御機構
○加藤 恒(大阪大学大学院医学系研究科血液・腫瘍内科)
[PL01-3]von Willebrand因子異常症からみた血栓止血制御機構 -出血と血栓の両方向へのADAMTS13の重要性
○松本 雅則, 藤村 吉博(奈良県立医科大学輸血部)
[PL01-4]本態性血小板血症解析からみた血小板造血制御機構
○小松 則夫(順天堂大学医学部内科学血液学講座)
[SSY01-1]血小板バイオロジー：抗GPIbα抗体ITPマウスモデルから得られた知見
○金地 泰典(スクリプス研究所分子医学部門)
[SSY01-2]血友病の病態解明と治療への応用
○大森 司(自治医科大学医学部生化学講座病態生化学部門)
[SSY01-3]血栓形成－溶解制御機構の時空間的解析
○鈴木 優子, 浦野 哲盟(浜松医科大学医学部医生理学講座)
[SSY01-4]血管内皮細胞の多様性の解明とその臨床応用
○内藤 尚道(大阪大学微生物病研究所情報伝達分野)
[SY01-1]幼若血小板比率(IPF%, RP%)測定とその臨床的意義
○櫻木 美基子, 林 悟, 冨山 佳昭(大阪大学医学部附属病院輸血部)
[SY01-2]可溶型血小板活性化受容体CLEC-2, Soluble CLEC-2 の産生機序と臨床応用
○井上 修(山梨大学医学部附属病院感染制御部)
[SY01-3]ループスアンチコアグラント検出における凝固波形解析の有用性
○徳永 尚樹(徳島大学病院医療技術部臨床検査技術部門)
[SY01-4]先天性プロテインS欠乏症およびプロテインS活性測定に影響する要因の検討
○長屋 聡美1,2, 森下 英理子1(1.金沢大学大学院医薬保健学総合研究科保健学専攻病態検査学講座, 2.医療法人社団浅ノ川 浅ノ川総合病院)
[SY01-5]後天性血友病における抗凝固因子インヒビター量の測定意義：ベセスダ法との比較を中心に
○大村 一将, 家子 正裕(北海道医療大学歯学部内科学分野)
[SS01-1]国際認証時代での若手の育成－医学教育の変貌を知る
○松尾 理(近畿大学医学部)
[OAWD01-1]「Utako Award」 Manufacture of Platelets from Human Adipose Tissue-derived Mesenchymal Stem Cell Line for Future Clinical Application
○Yumiko Matsubara1,2(1.Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan, 2.Department of Labolatory Medicine, Keio University School of Medicine, Tokyo, Japan)
[OAWD02-1]「Shosuke Award」 Blood coagulation regulation and thrombosis
○Tetsuhito Kojima(Aichi Health Promotion Foundation, Nagoya, Japan)
[JAJOS01-1]C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice
○Toshiaki Shirai(Department of Clinical and Laboratory Medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan)
[JAJOS01-2]Arrestin1 regulates GPCR-mediated platelet activation and thrombus formation
○Preeti Kumari Chaudhary, Sang Gu Kim, Soochong Kim(Veterinary Medicine, Chungbuk National University, Republic of Korea)
[JAJOS01-3]Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry
○Yugo Yamashita(Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan)
[JAJOS01-4]Development of a two-stage limb ischemia model to better simulate human peripheral artery disease
○Smriti Murali Krishna1,2, Jonathan Golledge1,2,3(1.Vascular Biology Unit, Queensland Research Centre for Peripheral Vascular Disease, School of Medicine and Dentistry, James Cook University, Australia, 2.Australian Institute of Tropical Health & Medicine, James Cook University, Australia, 3.Department of Vascular and Endovascular Surgery, The Townsville Hospital, Townsville, Queensland, Australia)
[JAJOS01-5]Circulating Plasmablasts Contribute to Antiphospholipid Antibody Production, Associated with Type I Interferon Upregulation
○Ryo Hisada(Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Japan)
[JAJOS01-6]The increasing bleeding risk from drug-drug interactions in patients with direct oral anticoagulants
○Ji Yun Lee1, Ju-Hyeon Lee1, Sung-Soon Kwon2, Hyeon-Jong Yang2, Yang-Ki Kim2, Soo-Mee Bang1(1.Department of Internal Medicine, Seoul National University Bundang Hospital, Republic of Korea, 2.Department of Internal Medicine, Soonchunhyang University Hospital)
[SPC1-1]Megakaryocytes and thrombocytes: evolutionary and physiological perspectives through animal models
○Takashi Kato, D.Sc.(Department of Biology, Faculty of Education and Integrated Arts and Sciences, and Integrative Bioscience and Biomedical Engineering, Graduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan)
[SPC1-2]Identification of the earliest human unipotent megakaryocyte progenitor
○Kohta Miyawaki1,2, Hiromi Iawasaki3, Takashi Jiromaru1, Takahiro Maeda4, Koichi Akashi1(1.Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, 2.Department of Pathology, Kurume University School of Medicine, Kurume, Japan, 3.Department of Hematology and Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, 4.Center for Cellular and Molecular Medicine, Kyushu University Hospital, Fukuoka, Japan)
[SPC1-3]Megakaryocytes and platelets from human adipose tissue-derived mesenchymal stem cell line
○Yumiko Matsubara1,2(1.Clinical and Translational Research Center, Keio University School of Medicine, Tokyo, Japan, 2.Department of Labolatory Medicine, Keio University School of Medicine, Tokyo, Japan)
[SPC1-4]Unexpected mechanism of platelet biogenesis: lesson from large scaled platelet production in vitro
○Koji Eto1,2(1.CiRA, Kyoto University, Kyoto, Japan, 2.Chiba University Graduate School of Medicine, Chiba, Japan)
[SPC2-1]Generation of high-functional human iPS cell-derived hepatocyte-like cells and application for the treatment of hemophilia
○Hiroyuki Mizuguchi1,2,3,4(1.Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2.Global Center for Medical Engineering and Informatics, Osaka University, Osaka, Japan, 3.Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan, 4.Laboratory of Hepatocyte Regulation, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka, Japan)
[SPC2-2]Anti-coagulant activity of DNA aptamer and its neutralization by antidote single stranded DNA
○Keitaro Yoshimoto(Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo, Japan)
[SPC2-3]Role of PAR4 in viral infections
○Kohei Tatsumi1,2, Nigel Mackman2, Silvio Antoniak2(1.Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Japan, 2.Division of Hematology/Oncology, Department of Medicine, University of North Carolina at Chapel Hill, NC, U.S.A.)
[SPC2-4]Hereditary functional thrombomodulin deficiency, a new entity for congenital thrombophilia syndromes
○Masahiko Okada1, Goichi Honda2, Koji Suzuki3(1.Misakaeno-sono Ayumino-ie, Omura, Japan, 2.Department of Medical Affairs, Asahi Kasei Pharma Corporation, Tokyo, Japan, 3.Department of Molecular Pathobiology, Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan)
[SPC3-1]Structural and functional dynamics of vascular network formation
○Hiroyasu Kidoya1,2(1.Department of Signal Transduction, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan, 2.PRESTO, Japan Science and Technology Agency, Tokyo, Japan)
[SPC3-2]Cellular and molecular basis of the neurovascular link
○Yoshiaki Kubota(Department of Anatomy, Keio University School of Medicine, Tokyo, Japan)
[SPC3-3]Cullin-3-based E3 ubiquitin ligases as novel regulators of angiogenesis
○Tomohisa Sakaue1,2, Hironori Izutani2, Shigeki Higashiyama1(1.Department of Cell Growth and Tumor Regulation, Proteo-Science Center (PROS), Ehime University, Toon, Japan, 2.Department of Cardiovascular and Thoracic Surgery, Ehime University Graduate School of Medicine, Ehime, Japan)
[SPC3-4]Mural cells are specified by artery-derived Notch signal
○Koji Ando, Shigetomo Fukuhara(Dept. of Mol. Pathophysiol., Inst. of Adv. Med. Sci., Nippon Med. School, Tokyo, Japan)
[SPC3-5]Role of platelets in blood-lymph partitioning
○Masanori Hirashima(Division of Pharmacology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan)
[SPC4-1]Using microfluidic devices to study blood-endothelium interface
○Toshiaki Shirai(Department of Clinical and laboratory medicine, Faculty of Medicine, University of Yamanashi, Chuo, Japan)
[SPC4-2]Intravital imaging analysis for the substance discharge in microcirculation with noninvasive optical microscopy
○Naoki Honkura1,2,3, Claesson-Welsh Lena2, Tetsumei Urano1(1.Department Medical physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan, 2.Department IGP, Rudbeck laboratory Uppsala University, Uppsala, Sweden, 3.PRESTO, JST)
[SPC4-3]Ultrastructural evidence of endothelial glycocalyx degradation in septic vasculitis
○Hideshi Okada(Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japan)
[SPC4-4]In vivo imaging of the cellular pathophysiology upon influenza virus infection using the two photon IMPRESS (IMaging Pathophysiology RESearch System)
○Hiroshi Ueki1, Yoshihiro Kawaoka1,2,3(1.Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan, 2.Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA, 3.Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo, Tokyo, Japan)
[JEMSS01-1]2019年におけるISTHの活動と2020に向けての抱負
○射場 敏明1, 山川 一馬2(1.順天堂大学救急・災害医学, 2.大阪急性期・総合医療センター高度救命救急センター)
[JEMSS01-2]COVID-19に伴う凝固異常に対するISTHの暫定ガイダンス
○射場 敏明(順天堂大学救急・災害医学)
276 results ( 1 - 50 )
- 1
- ...